The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$6.88

Today's change-0.17 -2.34%
Updated June 24 3:59 PM EDT. Delayed by at least 15 minutes.
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$6.88

Today's change-0.17 -2.34%
Updated June 24 3:59 PM EDT. Delayed by at least 15 minutes.

Nuvo Pharmaceuticals Inc crosses below 20-day moving average

Nuvo Pharmaceuticals Inc closed sharply lower Friday, dropping $0.17 or 2.34% to $6.88 and crossing below its 20-day moving average. Shares have lost 1.79% over the last five days, but have gained 31.96% over the last year to date. This security has outperformed the S&P TSX by 21.45% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward8.91×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.46
Updated June 24 3:59 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue8863
Total other revenue--------
Total revenue8863
Gross profit5531
Total cost of revenue3332
Total operating expense5879
Selling / general / administrative2333
Research & development0224
Depreciation / amortization0000
Interest expense (income), net operating--000
Unusual expense (income)--00--
Other operating expenses, total--------
Operating income20-2-6
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--0----
Other--------
Income before tax20-1-6
Income after tax20-1-6
Income tax, total0000
Net income-10-1-6
Total adjustments to net income--------
Net income before extra. items20-1-6
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items20-1-6
Inc. avail. to common incl. extra. items-10-1-6
Diluted net income-10-1-6
Dilution adjustment--------
Diluted weighted average shares11111111
Diluted EPS excluding extraordinary itemsvalue per share0.170.03-0.11-0.55
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.170.03-0.11-0.55